Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-113576
Filing Date
2024-10-08
Accepted
2024-10-08 17:08:24
Documents
1
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1459
  Complete submission text file 0000950170-24-113576.txt   2997
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 860 WASHIINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
Boyd Meta Cantey (Reporting) CIK: 0001784294 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38492 | Film No.: 241360909